Evaluating the Efficacy of Voice Therapy for Neurogenic Voice Disorders
Part of paid clinical trials in Austin, Texas.
- Sponsor
- University of Texas at Austin
- Study ID
- NCT07474740
- Status
- Active Not Recruiting
Conditions
- Speakers With Neurogenic Voice Disorders
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 90 Years
- Healthy Volunteers
- Not accepted
Interventions
- Breathy voice — BEHAVIORALParticipants will be trained to produce a breathy voice to reduce the perceptual severity of vocal tremor
Study Details
The goal of this study is to evaluate the efficacy of voice therapy for neurogenic voice disorders. The main questions are: Does voice therapy improve patient-reported quality of life in speakers with neurogenic voice disorders? Does voice therapy improve listener perception of voice in speakers with neurogenic voice disorders? Does voice therapy improve acoustical analyses of voice in speakers with neurogenic voice disorders? Does voice therapy improve physiologic function in speakers with neurogenic voice disorders?
Key Dates
- Start date
- Jun 4, 2024
- Status verified
- Mar 2026
- Primary completion
- Jun 4, 2028
- Completion
- Jun 4, 2028
Study Design
- Enrollment
- 40 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Breathy voice as a compensatory strategy for vocal tremor
Primary Outcome Measure
Patient-reported outcome measures [ Time Frame: Participants will complete ratings during the treatment phase at the beginning of the first treatment session and at the end of the last treatment session. ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| The University of Texas at Austin | Austin | Texas | 78712 | - |